NCT03966716 Hips Screws or (Total) Hip Replacement for Undisplaced Femoral Neck Fractures in Elderly Patients (HipSTHeR)
| NCT ID | NCT03966716 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Uppsala University |
| Condition | Femoral Neck Fractures |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,440 participants |
| Start Date | 2019-09-16 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,440 participants in total. It began in 2019-09-16 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A registerbased RCT will investigate whether arthroplasty can decrease the reoperation rate compared to internal fixation for patients with an undisplaced femoral neck fracture (Garden I-II).
Eligibility Criteria
Inclusion Criteria: * Undisplaced (Garden I-II) femoral neck fracture (within 72h) * treated at participating unit * informed consent * amenable for both treatment options Exclusion Criteria: * no informed consent * pathological or stress fracture * peri-implant fracture
Contact & Investigator
Stergios Lazarinis
STUDY CHAIR
Uppsala University Hospital
Frequently Asked Questions
Who can join the NCT03966716 clinical trial?
This trial is open to participants of all sexes, aged 75 Years or older, studying Femoral Neck Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03966716 currently recruiting?
Yes, NCT03966716 is actively recruiting participants. Contact the research team at olof.wolf@surgsci.uu.se for enrollment information.
Where is the NCT03966716 trial being conducted?
This trial is being conducted at Uppsala, Sweden, Alingsås, Sweden, Borås, Sweden, Falun, Sweden and 11 additional locations.
Who is sponsoring the NCT03966716 clinical trial?
NCT03966716 is sponsored by Uppsala University. The principal investigator is Stergios Lazarinis at Uppsala University Hospital. The trial plans to enroll 1,440 participants.